Humacyte Inc (HUMA) is reporting earnings next week. Lets focus in on how the stock is performing.
An EPS (earnings per share) of -$0.22 is expected to be reported by Humacyte Inc according to analyst consensus. Over the last 90 days, analysts have lowered estimates once. Management will host a conference call on August 12, 2022 to provide a corporate and financial update.
HUMA bulls will first be listening for news that the company beat the analysts' estimates. After that they'll want to hear that the company beat these expectations with robust revenues that were higher than expected. Finally they'll want to hear about a positive growth story that helps analysts frame the company's future as one of growth in the following quarters.
Meanwhile, out of a dark cave, HUMA bears will lumber into the light. They'll want to hear that the company underperformed the analysts' estimates and is set to decline in coming quarters. The less rosy the report, the happier bears will be.
If you haven't traded too many earnings reports, it's important to be aware that sometimes the majority of a stock's price movement can be caused by the analysts' estimates, rather than from the earnings report itself. As you see more of these, your ability to recognize one or the other will improve.
Shares of HUMA were trading at $3.47 as of August 04. Over the last 52-weeks, shares are down -80.11%. A larger percentage here can mean investors have a stronger bullish or bearish outlook on the stock.